TY - JOUR
T1 - Measuring the impact of COVID-19 vaccination and immunity waning
T2 - a modelling study for Portugal
AU - Caetano, Constantino
AU - Morgado, Maria Luísa
AU - Patrício, Paula
AU - Leite, Andreia
AU - Machado, Ausenda
AU - Torres, André
AU - Pereira, João Freitas
AU - Namorado, Sónia
AU - Sottomayor, Ana
AU - Peralta-Santos, André
AU - Nunes, Baltazar
N1 - Funding Information:
The authors acknowledge financial support from the Fundação para a Ciência e Tecnologia - FCT through project “Projection of the Impact of Non-pharmacological real-time Control and mitigation measures for the COVID-19 epidemic” (COVID-19 in-CTRL) - project n° 692 from the 2nd edition of RESEARCH 4 COVID-19. The first author also acknowledges FCT within the PhD grants program “DOCTORATES 4 COVID-19”, Grant No 2020.10172.BD. The second author also acknowledges FCT within projects UIDB/04621/2020 and UIDP/04621/2020. The third author also acknowledges FCT within the Strategic Project UIDB/00297 /2020 (Centro de Matemática e Aplicações, Universidade Nova de Lisboa ).
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/11/22
Y1 - 2022/11/22
N2 - Vaccination strategies to control COVID-19 have been ongoing worldwide since the end of 2020. Understanding their possible effect is key to prevent future disease spread. Using a modelling approach, this study intends to measure the impact of the COVID-19 Portuguese vaccination strategy on the effective reproduction number and explore three scenarios for vaccine effectiveness waning. Namely, the no-immunity-loss, 1-year and 3-years of immunity duration scenarios. We adapted an age-structured SEIR deterministic model and used Portuguese hospitalisation data for the model calibration. Results show that, although the Portuguese vaccination plan had a substantial impact in reducing overall transmission, it might not be sufficient to control disease spread. A significant vaccination coverage of those above 5 years old, a vaccine effectiveness against disease of at least 80% and softer non-pharmaceutical interventions (NPIs), such as mask usage and social distancing, would be necessary to control disease spread in the worst scenario considered. The immunity duration scenario of 1-year displays a resurgence of COVID-19 hospitalisations by the end of 2021, the same is observed in 3-year scenario although with a lower magnitude. The no-immunity-loss scenario presents a low increase in hospitalisations. In both the 1-year and 3-year scenarios, a vaccination boost of those above 65 years old would result in a 53% and 38% peak reduction of non-ICU hospitalisations, respectively. These results suggest that NPIs should not be fully phased-out but instead be combined with a fast booster vaccination strategy to reduce healthcare burden.
AB - Vaccination strategies to control COVID-19 have been ongoing worldwide since the end of 2020. Understanding their possible effect is key to prevent future disease spread. Using a modelling approach, this study intends to measure the impact of the COVID-19 Portuguese vaccination strategy on the effective reproduction number and explore three scenarios for vaccine effectiveness waning. Namely, the no-immunity-loss, 1-year and 3-years of immunity duration scenarios. We adapted an age-structured SEIR deterministic model and used Portuguese hospitalisation data for the model calibration. Results show that, although the Portuguese vaccination plan had a substantial impact in reducing overall transmission, it might not be sufficient to control disease spread. A significant vaccination coverage of those above 5 years old, a vaccine effectiveness against disease of at least 80% and softer non-pharmaceutical interventions (NPIs), such as mask usage and social distancing, would be necessary to control disease spread in the worst scenario considered. The immunity duration scenario of 1-year displays a resurgence of COVID-19 hospitalisations by the end of 2021, the same is observed in 3-year scenario although with a lower magnitude. The no-immunity-loss scenario presents a low increase in hospitalisations. In both the 1-year and 3-year scenarios, a vaccination boost of those above 65 years old would result in a 53% and 38% peak reduction of non-ICU hospitalisations, respectively. These results suggest that NPIs should not be fully phased-out but instead be combined with a fast booster vaccination strategy to reduce healthcare burden.
KW - Compartmental models
KW - COVID-19
KW - Epidemiology
KW - SEIR model
KW - Vaccination
KW - Vaccine effectiveness waning
UR - http://www.scopus.com/inward/record.url?scp=85140987641&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2022.10.007
DO - 10.1016/j.vaccine.2022.10.007
M3 - Article
C2 - 36404429
AN - SCOPUS:85140987641
SN - 0264-410X
VL - 40
SP - 7115
EP - 7121
JO - Vaccine
JF - Vaccine
IS - 49
ER -